| 1 |
中国发展研究基金会. 中国发展报告2020：中国人口老龄化的发展趋势和政策[R]. 北京：中国发展出版社，2020.
|
| 2 |
王煜，杨莉，王瑞萍，等. 慢性心力衰竭与心脏康复[J]. 中国老年保健医学，2015，13(1): 94-96.
|
| 3 |
李航. 肌少症的研究现状及进展[J]. 西南军医，2020，22(3): 229-231.
|
| 4 |
Wang H, Hai S, Cao L, et al. Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people[J]. BMC Geriatr, 2016, 16 (1): 216.
|
| 5 |
范利. 老年肌少症和衰弱综合征之间的关系[J]. 中华保健医学杂志，2014，16(6): 415-416.
|
| 6 |
杨文涛，周长喜，王玉堂，等. 慢性心力衰竭合并肌少症的研究进展[J]. 老年医学与保健，2019，25(6): 857-860.
|
| 7 |
Marchitto N, Sindona F, Mobilia P, et al. Effect of low-dose sacubitril/valsartan on body composition, bioelectrical impedance analysis, heart rate variability and T-peak to T-end index in elderly patients with severe chronic heart failure: a pilot experience[J]. Curr Med Res Opin, 2019, 35 (Suppl 1): 13-15.
|
| 8 |
Suzuki T, Palus S, Springer J. Skeletal muscle wasting in chronic heart failure[J]. ESC Heart Fail, 2018, 5 (6): 1099-1107.
|
| 9 |
崔怡宁，孙颖. 老年慢性心力衰竭合并肌少症的研究进展[J]. 中华老年心脑血管病杂志，2018，20(6): 656-658.
|
| 10 |
黄榆杰. 白藜芦醇对肥胖性肌肉衰减症的作用及机制研究[D]. 重庆：中国人民解放军陆军军医大学，2019.
|
| 11 |
Schulze PC, Gielen S, Adams V, et al. Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulin like growth factor-I in chronic heart failure[J]. Basic Res Cardiol, 2003, 98 (4): 267-274.
|
| 12 |
Toth MJ, Ades PA, Tischler MD, et al. Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure[J]. Int J Cardiol, 2006, 109 (2): 179-187.
|
| 13 |
Matsumori A, Yamada T, Suzuki H, et al. Increased circulating cytokines in patients with myocarditis and cardiomyopathy[J]. Br Heart J, 1994, 72 (6): 561-566.
|
| 14 |
Jankowska EA, von Haehling S, Czarny A, et al. Activation of the NF-kappaB system in peripheral blood leukocytes from patients with chronic heart failure[J]. Eur J Heart Fail, 2005, 7 (6): 984-990.
|
| 15 |
瓜超君，李铁军，王佳贺. 心力衰竭与肌少症的研究进展[J]. 实用老年医学，2020，34(3): 212-215.
|
| 16 |
Lenk K, Erbs S, Hollriegel R, et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure[J]. Eur J Prev Cardiol, 2012, 19 (3): 404-411.
|
| 17 |
王仁俊，周琴，未晓巍，等. 室旁核内脂肪酸酰胺水解酶上调介导慢性心衰大鼠交感神经兴奋亢进[J]. 中国病理生理杂志，2018，34(3): 385-392.
|
| 18 |
Verschure DO, van Eck-Smit BL, Somsen GA, et al. Cardiac sympathetic activity in chronic heart failure: cardiac 123I-mIBG scintigraphy to improve patient selection for ICD implantation[J]. Neth Heart J, 2016, 24 (12): 701-708.
|
| 19 |
Colucci WS. The effects of norepinephrine on myoc-ardial biology: implications for the therapy of heart failure[J]. Clin Cardiol, 1998, 21 (12 Suppl 1): I20-I24.
|
| 20 |
Morley JE, Thomas DR, Wilson MM. Cachexia: patho-physiology and clinical relevance[J]. Am J Clin Nutr, 2006, 83 (4): 735-743.
|
| 21 |
董馨，荣阳. 血管紧张素转换酶抑制剂与β受体阻滞剂联合应用治疗心力衰竭的临床研究[J]. 中国医药指南，2020，18(5): 136.
|
| 22 |
Breitbart A, Auger-Messier M, Molkentin JD, et al. Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting[J]. Am J Physiol Heart Circ Physiol, 2011, 300 (6): H1973-H1982.
|
| 23 |
杜雅丽，张静，刘芃宸，等. 肥胖与射血分数保留的心力衰竭关系的研究进展[J]. 医学综述，2019，25(12): 2393-2397.
|
| 24 |
Caminiti G, Volterrani M, Iellamo F, et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study[J]. J Am Coll Cardiol, 2009, 54 (10): 919-927.
|
| 25 |
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J, 2016, 37 (27): 2129-2200.
|
| 26 |
姜珊，康琳，刘晓红. 2019亚洲肌少症诊断及治疗共识解读[J]. 中华老年医学杂志，2020，39(4): 373-376.
|
| 27 |
Piepoli MF, Conraads V, Corrà U, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation[J]. Eur J Heart Fail, 2011, 13 (4): 347-357.
|
| 28 |
Cunha TF, Bacurau AV, Moreira JB, et al. Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure[J]. PLoS One, 2012, 7 (8): e41701.
|
| 29 |
张文婧，王佳贺. 老年肌少症与营养干预的研究进展[J]. 国际老年医学杂志，2020，41(2): 125-128.
|
| 30 |
Garcia M, Seelaender M, Sotiropoulos A, et al. Vita-min D, muscle recovery, sarcopenia, cachexia, and muscle atrophy[J]. Nutrition, 2019 (60): 66-69.
|
| 31 |
Wandrag L, Brett SJ, Frost G, et al. Impact of supplementation with amino acids or their metabolites on muscle wasting in patients with critical illness or other muscle wasting illness: a systematic review[J]. J Hum Nutr Diet, 2015, 28 (4): 313-330.
|
| 32 |
Aquilani R, Opasich C, Gualco A, et al. Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure[J]. Eur J Heart Fail, 2008, 10 (11): 1127-1135.
|
| 33 |
Onder G, Penninx BW, Balkrishnan R, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study[J]. Lancet, 2002, 359 (9310): 926-930.
|
| 34 |
Meinen S, Lin S, Rüegg MA. Angiotensin Ⅱ type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-alpha2-deficient congenital muscular dystrophy (MDC1A)[J]. Skelet Muscle, 2012, 2 (1): 18.
|